71 related articles for article (PubMed ID: 325178)
21. Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B.
Collins MS; Pappagianis D
Sabouraudia; 1974 Nov; 12(3):329-40. PubMed ID: 4610825
[No Abstract] [Full Text] [Related]
22. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
[TBL] [Abstract][Full Text] [Related]
23. Effect of a polyene antibiotic on growth and phosphate uptake by Candida albicans.
Berdicevsky I; Grossowicz N
J Gen Microbiol; 1977 Oct; 102(2):299-304. PubMed ID: 336844
[TBL] [Abstract][Full Text] [Related]
24. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
25. Differences in response in vivo to amphotericin B among Candida albicans strains.
O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans.
Phillips AJ; Sudbery I; Ramsdale M
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14327-32. PubMed ID: 14623979
[TBL] [Abstract][Full Text] [Related]
29. Nature and development of phenotypic resistance to amphotericin B in Candida albicans.
Gale EF
Adv Microb Physiol; 1986; 27():277-320. PubMed ID: 3532717
[No Abstract] [Full Text] [Related]
30. Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis.
Linares CE; Giacomelli SR; Altenhofen D; Alves SH; Morsch VM; Schetinger MR
Rev Soc Bras Med Trop; 2013; 46(6):752-8. PubMed ID: 24474018
[TBL] [Abstract][Full Text] [Related]
31. [Action of polyene antibiotics on ribosome binding with Candida albicans membranes].
Belousova II
Antibiotiki; 1977 Aug; 22(8):695-9. PubMed ID: 334049
[TBL] [Abstract][Full Text] [Related]
32. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
Chalkley LJ; Trinci AP; Pope AM
Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
[TBL] [Abstract][Full Text] [Related]
33. Effect of surface treatments of titanium on amphotericin B-treated Candida albicans persister cells.
Tsang CS; Tang DY
Mycoses; 2011 May; 54(3):189-94. PubMed ID: 19793205
[TBL] [Abstract][Full Text] [Related]
34. The release of potassium ions from Candida albicans in the presence of polyene antibiotics.
Gale EF
J Gen Microbiol; 1974 Feb; 80(2):451-65. PubMed ID: 4596987
[No Abstract] [Full Text] [Related]
35. In vitro susceptibility and resistance of Candida spp. to hamycin.
Athar MA
Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
[No Abstract] [Full Text] [Related]
36. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin.
O'Day DM; Ray WA; Robinson RD; Head WS
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):596-603. PubMed ID: 3549613
[TBL] [Abstract][Full Text] [Related]
37. [Sterol affinity of Candida albicans cells resistant to polyene antibiotics].
Virina AM; Belousova II; Tereshin IM
Antibiotiki; 1979 Oct; 24(10):755-8. PubMed ID: 386937
[TBL] [Abstract][Full Text] [Related]
38. Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
Szlinder-Richert J; Cybulska B; Grzybowska J; Borowski E; Prasad R
Acta Biochim Pol; 2000; 47(1):133-40. PubMed ID: 10961686
[TBL] [Abstract][Full Text] [Related]
39. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
[TBL] [Abstract][Full Text] [Related]
40. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans.
Kumar R; Shukla PK
Fungal Biol; 2010; 114(2-3):189-97. PubMed ID: 20943129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
